As part of $800M investment, Pfizer opens gene therapy facility in NC for early-stage productionnews2021-12-16T06:52:02+00:00December 16th, 2021|Fierce Pharma|
In its old age, Bristol Myers’ Orencia becomes first drug approved for preventing graft-versus-host diseasenews2021-12-15T20:38:00+00:00December 15th, 2021|Fierce Pharma|
Eli Lilly trots out rosy 2022 projections, sees recent launches driving two-thirds of its businessnews2021-12-15T16:30:35+00:00December 15th, 2021|Fierce Pharma|
AbbVie’s Rinvoq, Pfizer’s Xeljanz win new uses after extended reviews as JAK safety woes lingernews2021-12-15T14:46:21+00:00December 15th, 2021|Fierce Pharma|
Sayonara, San Francisco. #JPM22 is going virtual, thanks to COVIDnews2021-12-15T14:38:22+00:00December 15th, 2021|Fierce Pharma|
Abbott’s research initiative finds gap between perceived and actual patient experience in vascular carenews2021-12-15T10:17:55+00:00December 15th, 2021|Fierce Pharma|
For the first time, England’s NICE blesses PrEP drugs to prevent HIVnews2021-12-14T19:54:00+00:00December 14th, 2021|Fierce Pharma|
Aerami Therapeutics, eager to breeze into smart inhaler market, unveils $250M SPAC dealnews2021-12-14T18:23:50+00:00December 14th, 2021|Fierce Pharma|
Texas launches investigation of AbbVie, Endo for alleged off-label promotion of puberty blocking drugsnews2021-12-14T16:20:52+00:00December 14th, 2021|Fierce Pharma|
Lannett to shutter Silarx liquid drug manufacturing facility in New York, lay off 72 workersnews2021-12-14T16:00:31+00:00December 14th, 2021|Fierce Pharma|
